Related references
Note: Only part of the references are listed.Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies - Mature results of the French phase II RTF-1 trial
Francoise Mornex et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Assessment of residual error in liver position using kV cone-beam computed tomography for liver cancer high-precision radiation therapy
Maria A. Hawkins et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Individualized image guided iso-NTCP based liver cancer SBRT
Laura A. Dawson et al.
ACTA ONCOLOGICA (2006)
Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study
Alejandra Mendez Romero et al.
ACTA ONCOLOGICA (2006)
Stereotactic radiotherapy of primary liver cancer and hepatic metastases
Joern Wulf et al.
ACTA ONCOLOGICA (2006)
Phase II study of erlotinib in patients with advanced biliary cancer
Philip A. Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy
C Eccles et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies
E Ben-Josef et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma
W Yeo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
PA Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control
LA Dawson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients
T Chiba et al.
CLINICAL CANCER RESEARCH (2005)
Four-dimensional computed tomography: Image formation and clinical protocol
E Rietzel et al.
MEDICAL PHYSICS (2005)
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: A phase II trial
JJ Knox et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Local radiotherapy for patients with unresectable hepatocellular carcinoma
W Park et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Hepatocellular carcinoma -: survival and clinical characteristics in relation to various histologic molecular markers in Western patients
M Schöniger-Hekele et al.
LIVER INTERNATIONAL (2005)
Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization
MT Liu et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients
J Seong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Radiofrequency ablation of liver tumors: Influence of technique and tumor size
BW Kuvshinoff et al.
SURGERY (2002)
Transarterial chemoembolization for unresectable hepatocellular carcinoma:: Meta-analysis of randomized controlled trials
C Cammà et al.
RADIOLOGY (2002)
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients
L Solbiati et al.
RADIOLOGY (2001)
Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial
KK Herfarth et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies
LA Dawson et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
